Showing results (241-250 of 291) with videos related to

Sort By:
Pageof 30
Pancreas|June 24, 2009
Increase of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybridsCarsten Ziske, Patricia E Etzrodt, Alex-S Eliu, et al.
In Vivo (Athens, Greece)|March 16, 2007
Minimal size MIDGE vectors improve transgene expression in vivoFrank Schakowski, Marcus Gorschlüter, Peter Buttgereit, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Fluorescent Probes for Ecto-5'-nucleotidase (CD73)Constanze C Schmies, Georg Rolshoven, Riham M Idris, et al.
Anticancer Research|October 2, 2019
FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer CellsMaria Fitria Setiawan, Oliver Rudan, Annabelle Vogt, et al.
German Medical Science : GMS E-Journal|June 24, 2011
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysisKatrin Patrij, Marcel Reiser, Luise Wätzel, et al.
JHEP Reports : Innovation in Hepatology|October 23, 2025
What we missed then, AI sees now: Revisiting legacy large extracellular vesicle data to reveal synergistic biomarkers for liver cancer screeningArnulf G Willms, Marcin Krawczyk, Henrike Julich-Haertel, et al.
Journal of Extracellular Biology|September 3, 2024
Monocyte derived large extracellular vesicles in polytraumaAliona Wöhler, Sabine K Gries, Rebekka J S Salzmann, et al.
Cancer Immunology, Immunotherapy : CII|November 20, 2002
Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trialAngela Märten, Dimitri Flieger, Sabine Renoth, et al.
Leukemia|March 23, 2007
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yieldI Breitkreutz, H M Lokhorst, M S Raab, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 5, 2013
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple MyelomaBritta Auel, Hartmut Goldschmidt, Thomas Geer, et al.
Pageof 30